Back to Search
Start Over
European Registry on Helicobacter pylori management (Hp-EuReg): patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 533 patients
- Source :
- Gut, Gut, 2020, pp.gutjnl-2020-321372. ⟨10.1136/gutjnl-2020-321372⟩, Zaguán. Repositorio Digital de la Universidad de Zaragoza, Consejo Superior de Investigaciones Científicas (CSIC), Gut, BMJ Publishing Group, 2020, pp.gutjnl-2020-321372. ⟨10.1136/gutjnl-2020-321372⟩
- Publication Year :
- 2020
- Publisher :
- HAL CCSD, 2020.
-
Abstract
- ObjectiveThe best approach for Helicobacter pylori management remains unclear. An audit process is essential to ensure clinical practice is aligned with best standards of care.DesignInternational multicentre prospective non-interventional registry starting in 2013 aimed to evaluate the decisions and outcomes in H. pylori management by European gastroenterologists. Patients were registered in an e-CRF by AEG-REDCap. Variables included demographics, previous eradication attempts, prescribed treatment, adverse events and outcomes. Data monitoring was performed to ensure data quality. Time-trend and geographical analyses were performed.Results30 394 patients from 27 European countries were evaluated and 21 533 (78%) first-line empirical H. pylori treatments were included for analysis. Pretreatment resistance rates were 23% to clarithromycin, 32% to metronidazole and 13% to both. Triple therapy with amoxicillin and clarithromycin was most commonly prescribed (39%), achieving 81.5% modified intention-to-treat eradication rate. Over 90% eradication was obtained only with 10-day bismuth quadruple or 14-day concomitant treatments. Longer treatment duration, higher acid inhibition and compliance were associated with higher eradication rates. Time-trend analysis showed a region-dependent shift in prescriptions including abandoning triple therapies, using higher acid-inhibition and longer treatments, which was associated with an overall effectiveness increase (84%–90%).ConclusionManagement of H. pylori infection by European gastroenterologists is heterogeneous, suboptimal and discrepant with current recommendations. Only quadruple therapies lasting at least 10 days are able to achieve over 90% eradication rates. European recommendations are being slowly and heterogeneously incorporated into routine clinical practice, which was associated with a corresponding increase in effectiveness.
- Subjects :
- Male
Registrie
Proton Pump Inhibitor
Practice Patterns
0302 clinical medicine
Clarithromycin
Prospective Studies
Registries
Practice Patterns, Physicians'
[SDV.MHEP] Life Sciences [q-bio]/Human health and pathology
biology
Gastroenterology
Middle Aged
Anti-Bacterial Agents
3. Good health
Europe
030220 oncology & carcinogenesis
Combination
030211 gastroenterology & hepatology
Drug Therapy, Combination
Female
medicine.drug
Human
Adult
medicine.medical_specialty
TRIPLE THERAPY
QUADRUPLE THERAPY
CONSENSUS
INFECTION
METAANALYSIS
CLARITHROMYCIN
GUIDELINES
RESISTANCE
ARTICLE
Settore MED/12 - GASTROENTEROLOGIA
First line
Helicobacter Infections
03 medical and health sciences
Drug Therapy
Internal medicine
Anti-Bacterial Agent
medicine
Humans
Medical prescription
Adverse effect
Aged
Physicians'
Helicobacter pylori
business.industry
helicobacter pylori - treatment
Proton Pump Inhibitors
Amoxicillin
biology.organism_classification
Metronidazole
Prospective Studie
Concomitant
helicobacter pylori
business
Helicobacter Infection
[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
Subjects
Details
- Language :
- English
- ISSN :
- 00175749 and 14683288
- Database :
- OpenAIRE
- Journal :
- Gut, Gut, 2020, pp.gutjnl-2020-321372. ⟨10.1136/gutjnl-2020-321372⟩, Zaguán. Repositorio Digital de la Universidad de Zaragoza, Consejo Superior de Investigaciones Científicas (CSIC), Gut, BMJ Publishing Group, 2020, pp.gutjnl-2020-321372. ⟨10.1136/gutjnl-2020-321372⟩
- Accession number :
- edsair.doi.dedup.....95329bb53a89c7ff72ca12afbb081904
- Full Text :
- https://doi.org/10.1136/gutjnl-2020-321372⟩